A previous population study provides high-quality evidence that ACE-I is protective against ALS.46 The mechanism underpinning this observation is still unclear, but our discovery that bradykinin is protective suggests that the action of ACE-I to inhibit the degradation of bradykinin may be crucial. The gene discussed is KNG1; the disease is amyotrophic lateral sclerosis.